Simponi Maintains Long-Term Effects in UC Patients, GO-COLITIS Results Show
News
Results from the GO-COLITIS clinical trial (NCT02092285) confirm that the long-term effects of Janssen Pharmaceutical’s Simponi (golimumab) were maintained in patients with ulcerative colitis (UC), according to MSD, sponsor of the study. The United Kingdom ... Read more